Subscribe to RSS
Download PDF
DOI: 10.4103/ijmpo.ijmpo_33_18
MUC2 and MUC5AC Expression in Colon Cancer: A Preliminary Report from South India
Financial support and sponsorship Nil.
Abstract
Background: There is scanty data from India regarding MUC protein expression from colorectal cancers (CRC) among Indian patients. Aim of the Study: The aim of this study is to assess the alterations in the expression of MUC2 and MUC5AC in 25 patients with CRC by site of the tumor location and differentiation at histology. Materials and Methods: Patients with proven adenocarcinoma of the colon alone were included for the study. Biopsy specimens obtained from tumorous lesions in the colon were classified based on histopathology as well differentiated, moderately, and poorly differentiated adenocarcinoma. Immunohistochemistry was done in the 4 μm thick sections to identify the expression of MUC2 and MUC5AC mucins. Results: MUC2 was uniformly expressed with near similar intensity while MUC5 was moderately (56%) to highly expressed (36%) in mucinous tumors. In nonmucinous tumors, MUC2 was least expressed (68%) with a significant expression on MUC5AC (88%). Except for rectosigmoid growth which had greater expression of MUC5AC (31%), both proximal and distal carcinomas had significant MUC2 and MUC5AC expression. Conclusion: MUC2 and MUC5AC are expressed in colonic cancers, the former showing mildtomoderate expression and the latter moderatetointense expression. The expression is more in mucinous adenocarcinoma.
Publication History
Received: 09 February 2018
Accepted: 12 September 2018
Article published online:
03 June 2021
© 2019. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004; 23: 77-99
- 2 Aksoy N, Corfield AP, Sheehan JK. Preliminary study pointing out a significant alteration in the biochemical composition of MUC2 in colorectal mucinous carcinoma. Clin Biochem 2000; 33: 167-73
- 3 Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J. et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 15286-93
- 4 Lan MS, Batra SK, Qi WN, Metzgar RS, Hollingsworth MA. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 1990; 265: 15294-9
- 5 Ligtenberg MJ, Vos HL, Gennissen AM, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 1990; 265: 5573-8
- 6 Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport DT, Kim YS. et al. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 1989; 264: 6480-7
- 7 Taylor CR. Standardization in immunohistochemistry: The role of antigen retrieval in molecular morphology. Biotech Histochem 2006; 81: 3-12
- 8 Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S. et al. Colorectal cancer in mice genetically deficient in the mucin muc2. Science 2002; 295: 1726-9
- 9 Bu XD, Li N, Tian XQ, Li L, Wang JS, Yu XJ. et al. Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. World J Gastroenterol 2010; 16: 4089-94
- 10 Farhat MH, Barada KA, Tawil AN, Itani DM, Hatoum HA, Shamseddine AI. et al. Effect of mucin production on survival in colorectal cancer: A case-control study. World J Gastroenterol 2008; 14: 6981-5
- 11 Voloshanenko O, Erdmann G, Dubash TD, Augustin I, Metzig M, Moffa G. et al. Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells. Nat Commun 2013; 4: 2610
- 12 Ookawa K, Kudo T, Aizawa S, Saito H, Tsuchida S. Transcriptional activation of the MUC2 gene by p53. J Biol Chem 2002; 277: 48270-5
- 13 Lugli A, Zlobec I, Baker K, Minoo P, Tornillo L, Terracciano L. et al. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status. J Clin Pathol 2007; 60: 534-9
- 14 Kocer B, Soran A, Erdogan S, Karabeyoglu M, Yildirim O, Eroglu A. et al. Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int 2002; 52: 470-7
- 15 Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ, Nagler B. et al. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the cpG island methylator phenotype. Mod Pathol 2013; 26: 1642-56
- 16 Betge J, Schneider NI, Harbaum L, Pollheimer MJ, Lindtner RA, Kornprat P. et al. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: Expression profiles and clinical significance. Virchows Arch 2016; 469: 255-65